Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1978 1
1979 2
1990 2
1996 1
1997 1
1998 2
1999 1
2000 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Letrozole: which dose to be used?
Buzdar AU, Chaudri HA, Trunet PF. Buzdar AU, et al. Among authors: chaudri ha. J Clin Oncol. 2000 Apr;18(8):1802-3. doi: 10.1200/JCO.2000.18.8.1802. J Clin Oncol. 2000. PMID: 10764444 No abstract available.
How long should long be? Long-term trials in rheumatic diseases.
Ciccolunghi SN, Chaudri HA, Schubiger BI. Ciccolunghi SN, et al. Among authors: chaudri ha. Ann Rheum Dis. 1979 Apr;38(2):155-60. doi: 10.1136/ard.38.2.155. Ann Rheum Dis. 1979. PMID: 375851 Free PMC article. Clinical Trial.
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.
Dombernowsky P, Smith I, Falkson G, Leonard R, Panasci L, Bellmunt J, Bezwoda W, Gardin G, Gudgeon A, Morgan M, Fornasiero A, Hoffmann W, Michel J, Hatschek T, Tjabbes T, Chaudri HA, Hornberger U, Trunet PF. Dombernowsky P, et al. Among authors: chaudri ha. J Clin Oncol. 1998 Feb;16(2):453-61. doi: 10.1200/JCO.1998.16.2.453. J Clin Oncol. 1998. PMID: 9469328 Clinical Trial.
Letrozole, a new oral aromatase inhibitor: randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer. Letrozole International Trial Group (AR/BC3).
Gershanovich M, Chaudri HA, Campos D, Lurie H, Bonaventura A, Jeffrey M, Buzzi F, Bodrogi I, Ludwig H, Reichardt P, O'Higgins N, Romieu G, Friederich P, Lassus M. Gershanovich M, et al. Among authors: chaudri ha. Ann Oncol. 1998 Jun;9(6):639-45. doi: 10.1023/a:1008226721932. Ann Oncol. 1998. PMID: 9681078 Free article. Clinical Trial.
13 results